All In Biotech

Drug Trial Radar · NCT00934921

Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions

A Relative Bioavailability Study of Ondansetron HCl 8 mg Orally Disintegrating Tablets Under Non-Fasting Conditions

Last checked: Nov 19, 2026Latest source record: Aug 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

24

Actual

Start

Feb 2003

Primary completion

Feb 2003

Study completion Feb 2003

Sponsor

Lead sponsor
Teva Pharmaceuticals USATeva (TEVA)
Sponsor type
Industry
First posted
Jul 8, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Crossover
Masking
None
Primary purpose
Other
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective of this study was to compare the relative bioavailability of the test formulation of Ondansetron HCl with the already marketed reference formulation Zofran® ODT under non-fasting conditions in healthy, non-smoking, adult subjects.

Conditions

  • Healthy

Interventions

  • OndansetronDrug

    1 x 8 mg Orally Disintegrating Tablet

  • Zofran®Drug

    1 x 8 mg ODT

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cmax - Maximum Observed ConcentrationTime frame: Blood samples collected over 24 hour period
  2. AUC0-inf - Area Under the Concentration-time Curve From Time Zero to Infinity (Extrapolated)Time frame: Blood samples collected over 24 hour period
  3. AUC0-t - Area Under the Concentration-time Curve From Time Zero to Time of Last Non-zero Concentration (Per Participant)Time frame: Blood samples collected over 24 hour period

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Novum Pharmaceutical Research Services

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.